By disrupting the function of Uba1 in nearly all of the major cell types in the BM, our study showed that null mutations of Uba1 in NEs rather than in other tested hematopoietic cells are critical for inducing VEXAS-like symptoms. This evidence concerns the gene UBA1 and VEXAS syndrome.